PIK3CA and breast cancer: A meta-analysis of 1929 breast cancer cases identified PIK3CA mutations as independent negative prognostic factors, with a hazard ratio of 1.67 (95% CI: 1.15–2.43; p = 0.007) and an associated reduction in median OS by 8.4 months [32].